Yarrow Bioscience Inc YARW
19.63 USD +1.58 (+8.75%)
At closeNov 12, 2026, 4:00 PM EST
19.63 0.00 0.00%
After hours · Nov 12, 4:00 PM ET
17.34 Day range 19.92
12.39 52-week range 46.95
- YTD
- -32.31%
- 1 year
- +11.53%
- Market cap
- 182.64M
- YTD return
- -32.31%
- 1-year return
- +11.53%
- Volume
- 134.60K
- Avg volume
- 138.49K
- Open
- 17.35
- Previous close
- 18.05
- Day's range
- 17.34 – 19.92
- 52-week range
- 12.39 – 46.95
5D +4.68 (+33.91%)
Financials — quick view
YARW Revenue — quarterly 97.00K
YARW Net income — quarterly -3.01M
YARW EPS — quarterly -3.51
News
Yarrow Bioscience Q3 EPS $(0.43) Misses $(0.32) Estimate 
Yarrow Bioscience Reports Third Quarter 2026 Financial Results and Provides Business Update 
12 Health Care Stocks Moving In Wednesday's Intraday Session 
This Palatin Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday 
Guggenheim Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $60 
Buy, Sell, or Hold? Friday’s Top Upgrades and Downgrades: Becton Dickinson, BJ’s Wholesale Club, Cogent Communications, Fervo Energy, JinkoSolar, Molson-Coors, Pfizer, SiTime, Steven Madden, and More 
Yarrow Bioscience Announces Participation in November Investor Events 
Contrasting Yarrow Bioscience (NASDAQ:YARW) and Atara Biotherapeutics (NASDAQ:ATRA) 
Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares 
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
Your note
Sign in to keep a note on YARW — it syncs with the Stock Master app.